SHUKRAPHARPharmaceuticals
Shukra Pharmaceuticals Ltd — Balance Sheet
₹30.34
-3.42%
Shukra Pharmaceuticals Ltd Balance Sheet (Annual)
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Ordinary Shares Number | 43.79 Cr | 43.79 Cr | 7.20 Cr | 30.09 Cr | — |
| Share Issued | 43.79 Cr | 43.79 Cr | 7.20 Cr | 30.09 Cr | — |
| Net Debt | 4.18 Cr | 3.15 Cr | 1.11 Cr | 3.09 Cr | — |
| Total Debt | 4.18 Cr | 3.15 Cr | 5.08 Cr | 3.38 Cr | — |
| Tangible Book Value | 62.84 Cr | 57.64 Cr | 25.30 Cr | 16.35 Cr | — |
| Invested Capital | 67.01 Cr | 60.79 Cr | 30.38 Cr | 19.73 Cr | — |
| Working Capital | 48.14 Cr | 42.08 Cr | 10.57 Cr | 3.50 Cr | — |
| Net Tangible Assets | 62.84 Cr | 57.64 Cr | 25.30 Cr | 16.35 Cr | — |
| Common Stock Equity | 62.84 Cr | 57.64 Cr | 25.30 Cr | 16.35 Cr | — |
| Total Capitalization | 65.95 Cr | 60.30 Cr | 29.07 Cr | 19.48 Cr | — |
| Total Equity Gross Minority Interest | 62.84 Cr | 57.64 Cr | 25.30 Cr | 16.35 Cr | — |
| Stockholders Equity | 62.84 Cr | 57.64 Cr | 25.30 Cr | 16.35 Cr | — |
| Other Equity Interest | 19.05 Cr | 46.69 Cr | 21.38 Cr | 14.78 Cr | — |
| Capital Stock | 43.79 Cr | 10.95 Cr | 3.91 Cr | 1.57 Cr | — |
| Common Stock | 43.79 Cr | 10.95 Cr | 3.91 Cr | 1.57 Cr | — |
| Total Liabilities Net Minority Interest | 23.93 Cr | 20.20 Cr | 49.67 Cr | 18.76 Cr | — |
| Total Non Current Liabilities Net Minority Interest | 6.65 Cr | 6.04 Cr | 7.16 Cr | 6.39 Cr | — |
| Other Non Current Liabilities | 1000.00 | 1000.00 | 0.11 Cr | -2000.00 | — |
| Non Current Deferred Taxes Liabilities | 3.41 Cr | 3.27 Cr | 3.29 Cr | 3.26 Cr | — |
| Long Term Debt And Capital Lease Obligation | 3.11 Cr | 2.66 Cr | 3.77 Cr | 3.13 Cr | — |
| Long Term Debt | 3.11 Cr | 2.66 Cr | 3.77 Cr | 3.13 Cr | — |
| Long Term Provisions | 0.13 Cr | 0.11 Cr | — | — | — |
| Current Liabilities | 17.28 Cr | 14.15 Cr | 42.51 Cr | 12.38 Cr | — |
| Other Current Liabilities | 4.27 Cr | 1.01 Cr | -1000.00 | 1000.00 | — |
| Current Debt And Capital Lease Obligation | 1.06 Cr | 0.50 Cr | 1.31 Cr | 0.25 Cr | — |
| Current Debt | 1.06 Cr | 0.50 Cr | 1.31 Cr | 0.25 Cr | — |
| Current Provisions | 2.74 Cr | 0.84 Cr | 0.03 Cr | — | 0.85 Cr |
| Payables | 9.22 Cr | 8.25 Cr | 34.52 Cr | 9.38 Cr | — |
| Accounts Payable | 9.22 Cr | 7.22 Cr | 33.62 Cr | 8.59 Cr | — |
| Total Assets | 86.77 Cr | 77.84 Cr | 74.97 Cr | 35.11 Cr | — |
| Total Non Current Assets | 21.34 Cr | 21.60 Cr | 21.89 Cr | 19.24 Cr | — |
| Net PPE | 21.34 Cr | 21.60 Cr | 21.89 Cr | 19.24 Cr | — |
| Gross PPE | 21.34 Cr | 42.99 Cr | 41.23 Cr | 36.73 Cr | — |
| Construction In Progress | 1.95 Cr | 1.66 Cr | 1.66 Cr | 1.66 Cr | — |
| Other Properties | 19.40 Cr | 0.36 Cr | 0.36 Cr | 0.33 Cr | — |
| Current Assets | 65.43 Cr | 56.23 Cr | 53.07 Cr | 15.87 Cr | — |
| Other Current Assets | 23.64 Cr | 0.08 Cr | 13.22 Cr | 1000.00 | — |
| Inventory | 9.95 Cr | 2.31 Cr | 3.16 Cr | 3.95 Cr | — |
| Other Receivables | 10.23 Cr | 7.11 Cr | 9.25 Cr | 1.82 Cr | — |
| Taxes Receivable | 0.72 Cr | 0.81 Cr | 0.66 Cr | 0.57 Cr | — |
| Accounts Receivable | 8.77 Cr | 24.51 Cr | 30.19 Cr | 7.40 Cr | — |
| Cash Cash Equivalents And Short Term Investments | 12.12 Cr | 9.98 Cr | 3.97 Cr | 0.29 Cr | — |
| Other Short Term Investments | 12.12 Cr | 9.98 Cr | — | — | 3.43 Cr |
| Retained Earnings | — | 37.56 Cr | 19.11 Cr | 14.78 Cr | 14.03 Cr |
| Additional Paid In Capital | — | 9.12 Cr | 2.28 Cr | 0.00 | — |
| Non Current Pension And Other Postretirement Benefit Plans | — | 0.11 Cr | 0.11 Cr | — | — |
| Pensionand Other Post Retirement Benefit Plans Current | — | 0.04 Cr | 0.03 Cr | 0.28 Cr | 0.69 Cr |
| Other Payable | — | 1.00 Cr | 0.85 Cr | 0.13 Cr | 25000.00 |
| Dividends Payable | — | 0.03 Cr | 0.04 Cr | 0.04 Cr | 0.05 Cr |
| Other Non Current Assets | — | 357.79 | 340.08 | 12000.00 | -1315.00 |
| Accumulated Depreciation | — | -21.38 Cr | -19.33 Cr | -17.49 Cr | -15.83 Cr |
| Machinery Furniture Equipment | — | 28.27 Cr | 27.36 Cr | 24.52 Cr | 22.98 Cr |
| Buildings And Improvements | — | 12.53 Cr | 11.67 Cr | 10.05 Cr | 10.04 Cr |
| Land And Improvements | — | 0.17 Cr | 0.17 Cr | 0.17 Cr | 0.17 Cr |
| Properties | — | 0.00 | 0.00 | 0.00 | 0.00 |
| Current Deferred Assets | — | 0.09 Cr | 0.11 Cr | 0.11 Cr | 0.11 Cr |
| Prepaid Assets | — | 11.33 Cr | 5.74 Cr | 1.72 Cr | 2.04 Cr |
| Work In Process | — | 1.08 Cr | 1.79 Cr | 1.45 Cr | 0.68 Cr |
| Raw Materials | — | 1.23 Cr | 1.37 Cr | 2.50 Cr | 1.00 Cr |
| Cash And Cash Equivalents | — | 9.98 Cr | 3.97 Cr | 0.29 Cr | 0.50 Cr |
| Cash Equivalents | — | 9.53 Cr | 0.21 Cr | 0.20 Cr | — |
| Cash Financial | — | 0.45 Cr | 3.76 Cr | 0.09 Cr | 0.50 Cr |
| Total Tax Payable | — | — | 0.00 | 0.62 Cr | 0.12 Cr |
| Other Inventories | — | — | 1.37 Cr | 2.50 Cr | 0.96 Cr |
| Non Current Deferred Taxes Assets | — | — | — | 0.00 | 0.00 |
| Investmentin Financial Assets | — | — | — | 0.20 Cr | 0.19 Cr |
| Available For Sale Securities | — | — | — | 0.20 Cr | 0.19 Cr |
| Finished Goods | — | — | — | — | 0.00 |
| Gross Accounts Receivable | — | — | — | — | 8.90 Cr |
All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.
More on Shukra Pharmaceuticals Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.